Zydus seeks new drug for uncontrolled ‘bad’ cholesterol

Zydus seeks new drug for uncontrolled 'bad' cholesterol

Often referred to as bad cholesterol since it gets deposited in the walls of the blood vessels, LDL-c increases the chances of health problems such as heart attack or stroke.

Without precedent for India, Zydus Lifesciences Ltd. (previously Cadila Healthcare Ltd) has launched a new class of drug ‘Bemdac’ to treat uncontrolled low density lipoprotein cholesterol (LDL-c). With uncontrolled LDL-c representing a major risk of creating cardiovascular infections, the equivalent was lacking proper treatment despite patients’ life-style modifications and utilization of greatest endured dose of statins. Notwithstanding, presently addressing to the pressing healthcare need, the oral drug Bemdac will offer a new line of treatment for patients from uncontrolled levels of LDL-c.

Uncontrolled LDL-c currently leads to imbalance of lipids including cholesterol, LDL-c, triglycerides and high-density lipoprotein (HDL), commonly known as dyslipidemia. Citing various studies, Zydus Lifesciences on Friday stated that eight out of 10 Indians are dyslipidemic and 112 million adults suffer from high levels of LDL-c.

Moreover, seven out of 10 dyslipidemia patients who are on statin treatment continue to suffer from uncontrolled LDL-c. Besides, 5.4 million Indians are found to be intolerant to statin therapy. However, Bemdac’s Bempedoic acid has also shown to have good results in patients not able to tolerate statins and those who do not respond to statins.

With Zydus already having several leading brands to address cardiac care and dyslipidemia including Atorva, Clopitorva, Zyrova and Pivasta, Bemdac is now an important addition to the company’s portfolio of medicines for managing dyslipidemia and cholesterol, said Zydus Lifesciences’ managing director Dr. Sharvil Patel.

For instance, the company’s brand Atorva is a leader in the Atorvastatin market with a market share of 18.4 per cent, ranking second in terms of market share in the Rs 2162 crore statin segment, based on AWACS Report of February 2022.

Disclaimer: If you need to edit or update this news from compsmag then kindly contact us Learn more

For Latest News Follow us on Google News


Latest Headlines
  • Show all
  • Trending News
  • Popular By week
US economic outlook weakens, inflation likely to persist
Inflation sees the Fed’s path tilt a little
Meanwhile the consensus view on the unemployment rate in the next two years ticked up to just 3.8% from the current 3.6%, an outcome that would enthuse Fed ...
Maruti Suzuki selects a site in Haryana for a new production facility, with an initial investment of Rs 11,000 crore
Maruti Suzuki selects a site in Haryana for a new production facility, with an initial investment of Rs 11,000 crore
”There will be further investments as we go along,” Bhargava noted, without sharing any financial details. He said the facility would help the company cater ...
UCO Bank Q4 net profit jumps more than 3 times to Rs 312 cr as bad loans fall
UCO Bank Q4 net profit jumps more than 3 times to Rs 312 cr as bad loans fall
For the full fiscal FY22, the bank’s net profit grew more than five times to Rs 930 crore from Rs 167 crore in FY21. State-owned UCO Bank on Friday posted ...
US economic outlook weakens, inflation likely to persist
Russian inflation rises to 17.83% in April, highest since early 2002
Inflation in Russia has accelerated sharply after Russia began what it calls “a special military operation” in Ukraine on Feb. 24. Consumer inflation in ...
US job market still tightening;  Moderate producer cost gains
Wall Street’s ‘fear gauge’ offers no silver lining as bear market approaches
“Sentiment is negative out there but there is no real fear, there is no sense of panic,” said Kris Sidial, a co-founder at volatility arbitrage fund The ...
In Moscow, ruble rises above 63 against the dollar and hits new 5-year high against the euro
In Moscow, ruble rises above 63 against the dollar and hits new 5-year high against the euro
At 0723 GMT, the rouble was steady against the dollar at 63.32, earlier touching 62.6250, its strongest mark since Feb. 5, 2020, but banks are offering to ...
Zydus seeks new drug for uncontrolled 'bad' cholesterol
Zydus seeks new drug for uncontrolled ‘bad’ cholesterol
Often referred to as bad cholesterol since it gets deposited in the walls of the blood vessels, LDL-c increases the chances of health problems such as heart ...
Maruti Suzuki designs Rs 11,000 cr for new factory in Haryana
Maruti Suzuki designs Rs 11,000 cr for new factory in Haryana
The new plant’s first phase with a manufacturing capacity of 2.5 lakh units per annum is expected to be commissioned by 2025, subject to administrative ...
GLOBAL MARKETS-Global equities rise as US and European markets rebound
GLOBAL MARKETS-Global equities rise as US and European markets rebound
“There’s an awful lot of negative sentiment out there, we’re looking at a 40% chance of recession,” said Patrick Spencer, vice chairman of equities at Baird ...
PMI Electro plans to build a commercial electric vehicle factory in Maharashtra
PMI Electro plans to build a commercial electric vehicle factory in Maharashtra
With the upcoming facility in Pune, the total annual manufacturing capacity of PMI will grow to 4,000 electric CVs, the company said, adding that the new ...
Show next
We will be happy to hear your thoughts

Leave a reply

Compsmag - Latest News In Tech and Business
Logo